Henry Ford Health System
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Henry Ford Health System sits in the top decile of US sponsors by registered trial count (#140 of 15,742 sponsors by registered trial count).
Henry Ford Health System: 234 sponsored US clinical trials, 43 recruiting.
Henry Ford Health System sponsors 234 registered US clinical trials on ClinicalTrials.gov, 43 of them currently recruiting, and 148 completed. 35 of these trials are in Phase 3-4 (later-stage) and 38 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Insomnia, with 5 trials.
Top-decile sponsor footprint
Henry Ford Health System ranks in the top decile of sponsors by registered trial count (#140 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
148 of 173 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
234 total, page 2 of 5
Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization
NCT05478551
Anterior Cruciate Ligament Reconstruction Hybrid Remnant Repair
NCT05494073
Optimizing Phototesting and Investigating Photobiology of Visible Light
NCT05964907
Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
NCT05296590
Efficacy Evaluation of Products Against Long Wavelength Ultraviolet A1 and Visible Light Induced Biological Effects
NCT04181476
Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes
NCT03333122
Maneuvers to Reduce Laparoscopic Pain
NCT07583433
Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries
NCT07418853
Multimodal Analgesic Regimen for Total Hip Arthroplasty: An Initiative to Minimize Postoperative Opioid Use
NCT07672808
Sleep Patterns After Total Joint Replacement Surgery
NCT04896892
Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1
NCT07450183
Peer-Delivered Episodic Future Thinking for Returning Citizens
NCT06119503
Train Your Brain: A Pilot Project to Improve Memory and Decision Making
NCT05879198
Engaging Patients for Physical Exams During Virtual Care Visits
NCT05790811
Reducing Alcohol Use Post-Bariatric Surgery
NCT04788316
Preventing Insomnia With Virtual Oneshot Therapy (PIVOT)
NCT05523726
Intermittent Bolus vs Continuous Infusion Via ESP Catheters RCT
NCT05642416
Telemedicine Mindfulness-based Therapy for Perinatal Insomnia: An Open-label Trial.
NCT04443959
Feasibility of Semi-Permanent Tattoo for Treatment Alignment in Radiation Therapy
NCT05248009
Improving Future Thinking Among Mothers to Reduce Harsh Parenting and Improve Child Outcomes
NCT05229146
Use of Consumer Sleep Technology to Treat Shift Work Disorder
NCT05186233
Improving Delay Discounting to Decrease Harsh Parenting Among Parents Receiving Substance Use Treatment
NCT05229120
FOREward Together: Training Peer Recovery Coaches to Promote Retention and Adherence to MOUD
NCT05098795
Comparison of Intraoperative HR and RR Acquired Via ATLASense Raphael PolyMonitor and Standard Intraoperative Monitors
NCT05291949
Laser Treatment of Basal Cell Carcinoma Under Imaging Guidance
NCT05138328
Pressure-Volume Loop During High-Risk PCI
NCT04681313
Response to SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy Patients
NCT04723706
Improving Negative Stressful Perseverations in Insomnia to Revitalize Expectant Moms
NCT04445805
Toward High Fidelity Adaptive Radiotherapy in the Thorax
NCT04731571
Safety of Gebauer's Pain Ease and Gebauer's Ethyl Chloride
NCT04207710
Reduce Emotional Symptoms of Insomnia With SleepTreatment
NCT03724305
Use of Blood Flow Restriction (BFR) Therapy in Post-operative Rehabilitation Following Distal Biceps Tendon Repair
NCT04503421
SARS-CoV-2 IgG and IgM Serologic Assays
NCT04562246
Pre-visit Digital Messaging Improves Patient Reported Outcome Measure Participation Prior to the Orthopedic Ambulatory Visit
NCT04983641
Rapid Acute Coronary Syndrome Exclusion Using High-sensitivity I Troponin
NCT04488913
Use of Blood Flow Restriction Therapy Following ACL Tear
NCT04374968
Conduction Disease After Transcatheter Aortic Valve Replacement
NCT04489095
Cooled Versus Conventional Genicular Radiofrequency Ablation for Chronic Knee Pain
NCT04275128
The Effect of Midazolam Sedation on Diagnostic Medial Branch Blocks
NCT04453449
Sustained Immunity to COVID-19 as Measured by SARS-CoV-2 Serology Assays
NCT04562285
BFR Therapy in Patients With Rotator Cuff Tears
NCT04384120
Convalescent Plasma for Patients With COVID-19
NCT04385199
Will Hydroxychloroquine Impede or Prevent COVID-19
NCT04341441
Early Short Course Corticosteroids in COVID-19
NCT04374071
Evaluation of Outcomes in Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma
NCT04743999
Novel Decision Aid for Carpal Tunnel Patients
NCT04693273
Well-arm Exercise in Distal Radius Fractures
NCT04089709
Evaluating the Safety and Efficacy of Laight®-Therapy Treatment in Subjects With Hidradenitis Suppurativa
NCT05927948
Cilostazol and Nimodipine Combined Therapy After Aneurysmal Subarachnoid Hemorrhage (aSAH)
NCT04148105
HFHS-1801-A Pilot Study of Immunotherapy As Consolidation Therapy for Patients with Recurrent Head and Neck Cancer
NCT04188951
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 15 |
| Phase 2 | 23 |
| Phase 3 | 9 |
| Phase 4 | 26 |
Therapeutic Areas
What is open in the Henry Ford Health System pipeline
43 recruiting of 234 indexed (18% open); 148 completed (63%).
Phase mix: 35 late (III/IV) vs 38 early (I/II) (balanced across stages).
Top condition: Insomnia (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Henry Ford Health System: open-pipeline peers nationwide
Peers matched on 234 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
Henry Ford Health System sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 234 trials (± recruiting share)
- Daiichi Sankyo · 236 trials · 12% recruiting
- Loma Linda University · 237 trials · 15% recruiting
- Brown University · 231 trials · 15% recruiting
- University Hospitals Cleveland Medical Center · 230 trials · 18% recruiting
Sponsors near 18% open enrollment (± trial volume)
- New York Institute of Technology · 18% recruiting · 49 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of California, San Diego · 18% recruiting · 775 trials
Related
What to do with this Henry Ford Health System page
234 registered trials is a research-attention snapshot, not an endorsement of Henry Ford Health System or any single study.
- 43 of Henry Ford Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Insomnia is the condition Henry Ford Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Insomnia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Henry Ford Health System pipeline card: 234 registered trials from official public datasets.Report a data error.